Goodwin, Covington Lead Parabilis' $670M Upsized IPO
Venture-backed biotechnology firm Parabilis Medicines hit the public markets Wednesday after raising $670 million in its upsized initial public offering....To view the full article, register now.
Already a subscriber? Click here to view full article